HIGHLIGHTS
- who: James A. Bennett et al. from the Department Immunology and Microbial Disease, Albany Medical College, Albany, NY, USA have published the paper: Proof-of-Concept Study of an Alpha-Fetoprotein-Derived Peptide for the Management of Canine Mammary Cancer, in the Journal: Animals 2023, 13, 403. of /2023/
- what: The aim of this effort is to assess the tolerability of AFPep in higher mammalian species. Using mouse, dog, and monkey models, the authors report favorable pharmacokinetic and tolerability parameters for AFPep across these species, using doses and schedules that are therapeutic and preventive against . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.